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Abstract
In healthy individuals and those with insomnia, poor sleep quality is associated with decrements in performance on tests
of cognition, especially executive function. Sleep disturbances and cognitive deficits are both prevalent in Parkinson’s
disease (PD). Sleep problems occur in over 75% of patients, with sleep fragmentation and decreased sleep efficiency
being the most common sleep complaints, but their relation to cognition is unknown. We examined the association
between sleep quality and cognition in PD. In 35 non-demented individuals with PD and 18 normal control adults (NC),
sleep was measured using 24-hr wrist actigraphy over 7 days. Cognitive domains tested included attention and executive
function, memory and psychomotor function. In both groups, poor sleep was associated with worse performance on tests
of attention/executive function but not memory or psychomotor function. In the PD group, attention/executive function
was predicted by sleep efficiency, whereas memory and psychomotor function were not predicted by sleep quality.
Psychomotor and memory function were predicted by motor symptom severity. This study is the first to demonstrate that
sleep quality in PD is significantly correlated with cognition and that it differentially impacts attention and executive
function, thereby furthering our understanding of the link between sleep and cognition. (JINS, 2011, 18, 1–10)
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INTRODUCTION
Studies relating sleep to cognition in healthy individuals have
indicated that sleep quality may affect memory and executive
function. In healthy young adults, sleep has been implicated
in memory consolidation (Fowler, Sullivan, & Ekstrand, 1973;
Stickgold, 2005; Stickgold, Hobson, Fosse, & Fosse, 2001),
perceptual learning and visuospatial memory (Gais, Plihal,
Wagner, & Born, 2000; Karni, Tanne, Rubenstein, Askenasy, &
Sagi, 1994; Mednick, Makovski, Cai, & Jiang, 2009; Rasch,
Buchel, Gais, & Born, 2007; Stickgold, James, & Hobson, 2000;
Stickgold, Whidbee, Schirmer, Patel, & Hobson, 2000), REM-
dependent procedural learning (Smith, 2001), and development
of problem solving skills (Goel, Rao, Durmer, & Dinges, 2009;
Smith, 1993). Experimental studies of sleep restriction have
reported that, in younger adults, there is a dose-related
impairment in cognitive functioning after sleep deprivation
(Van Dongen, Maislin, Mullington, & Dinges, 2003).
In healthy older adults (ages 65 and over), relatively poor
sleep has been associated with lower global cognitive func-
tion and poorer performance on a test of executive function
and attention (Blackwell et al., 2006) as well as on working
memory, attentional set shifting, and abstract problem solving,
even after controlling for confounds such as cerebrovascular
disease, mood, and medication use (Nebes, Buysse, Halligan,
Houck, & Monk, 2009). Similar findings have been reported in
older adults (ages 55 and over) presenting with insomnia, who
have been shown to exhibit impairments on tasks of attention,
concentration, reaction time (Bastien et al., 2003; Haimov,
Hanuka, & Horowitz, 2008; Hauri, 1997), working memory
(Kuriyama, Mishima, Suzuki, Aritake, & Uchiyama, 2008), and
semantic memory (Mendelson, Garnett, Gillin, & Weingartner,
1984). Previous studies examining sleep and cognition did not
specifically examine whether there is a differential link between
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sleep and each of executive, memory, and psychomotor func-
tion. Some of the studies have reported that all three domains are
affected (Bastien et al., 2003; Haimov et al., 2008), whereas
others examined only executive or global function (Blackwell
et al., 2006).
Parkinson’s disease (PD) is a progressive neurodegenera-
tive disorder that is characterized by well-recognized motor
impairments and non-motor symptoms, including impair-
ments in cognition (Zgaljardic, Borod, Foldi, & Mattis, 2003)
and in sleep (Comella, 2003). Specific cognitive changes are
evident in many non-demented patients with PD who present
with deficits in executive function (Zgaljardic et al., 2003),
including problems with set shifting (Woodward, Bub, &
Hunter, 2002), internal control of attention (Brown & Marsden,
1988), working memory (Owen, Iddon, Hodges, Summers, &
Robbins, 1997) and verbal fluency (Henry & Crawford, 2004).
Verbal and visual memory as well as visuospatial function have
also been found to be compromised in PD (Amick, Grace, &
Chou, 2006; Cronin-Golomb, 2010).
Sleep problems in PD are among the most distressing non-
motor symptoms of the disease, impacting the quality of life
of patients and caregivers (Comella, 2006). Patients with PD
experience a variety of sleep disorders, including rapid eye
movement (REM) behavior disorder, sleep apnea, and restless
legs syndrome/periodic leg movements, and related sleep com-
plaints including sleep fragmentation, reduced sleep efficiency,
and excessive daytime sleepiness (Comella, 2006; Fahn, 2003).
Despite the prevalence of sleep problems as well as cognitive
impairment in PD, the relation of sleep disturbances to cognition
has only been examined with respect to REM behavior disorder
(RBD). Patients with RBD exhibit more impairment on tasks of
executive function (Sinforiani et al., 2006; Vendette et al., 2007),
memory and visuospatial function (Vendette et al., 2007),
suggesting that RBD heralds the beginning stages of a more
rapid dementing process. The general impact of sleep quality
on cognition in PD, however, has not been examined.
The pathophysiology of PD is widespread and affects
neural networks that are responsible for both cognitive func-
tion and sleep-wake regulation. The ascending progression of
Lewy neurite and Lewy body pathology appears to begin in the
brainstem and results in neuronal loss in the cholinergic, dopa-
minergic, and serotonergic systems. This pattern of pathology
affects the reticular activating system, implicated in sleep-wake
regulation and dream formation (Braak, Ghebremedhin, Rub,
Bratzke, & Del Tredici, 2004; Grinberg, Rueb, Alho, &
Heinsen, 2009; Hobson, Stickgold, & Pace-Schott, 1998) as
well as cortico-striato-thalamocortical circuits (Middleton &
Strick, 2001) important for cognitive function.
The literature relating sleep impairments to cognitive def-
icits in healthy adults and in those with insomnia suggests
that in any disorder that affects sleep, cognitive disturbance
may follow. As PD presents with both cognitive and sleep
impairments, we aimed to examine the impact of sleep
quality on cognitive functioning in individuals with PD,
using cognitive measures that are known to be affected by
both PD and sleep. We hypothesized that PD patients with
decreased sleep quality would exhibit greater impairments in
all tested cognitive domains than those whose sleep was less
disturbed. As PD presents with memory, attention/executive,
and psychomotor deficits, all of which have been reported
to be affected by sleep, our aim was to also explore whether
there is a differential impact of sleep on these cognitive
domains. We were especially interested in whether impair-
ments in sleep and cognition, should they co-occur, were
predicted by the same factors (e.g., disease severity) or instead
whether the association of sleep and cognition was independent
of disease-related characteristics.
METHODS
Participants
Thirty-five non-demented individuals with PD (22 men,
13 women; mean age, 66.2 years) were recruited from the
outpatient Movement Disorders Clinic at the Boston Uni-
versity School of Medicine. Eighteen normal control subjects
(NC) (8 men, 10 women; mean age, 64.4 years) were
recruited from the local community. The study was approved
by the Boston University Institutional Review Board and all
participants provided informed consent. The investigators
made an effort through the recruitment process to ensure that
PD and NC were matched overall on age and education.
Although there were more men in the PD group and more
women in the NC group, this difference was not significant
(w25 1.61; p. .05). On the modified Mini-Mental State
Examination (mMMSE) (Stern, Sano, Paulson, & Mayeux,
1987), a cut-off score of 27 was used for NC participants whereas
a cut-off score of 25 was used for PD participants, as this form of
the MMSE is particularly sensitive to specific cognitive deficits
found in PD without dementia (scores converted from the
57-point scale). Individuals with a history of substance abuse,
head injury or neurologic disorders besides PD were excluded.
None of the patients met criteria for Dementia with Lewy Bodies
as per McKeith and colleagues (2005). By participant self-report,
all NC were healthy with no diagnosed sleep, psychiatric, or
neurological disorders, and none were taking any sleep or psy-
chiatric medications. All NC were right-handed. PD participants
were right-handed except for two who were left-handed. Nine PD
patients reported having been diagnosed with REM behavior
disorder (RBD) or reported acting out their dreams at night,
which is indicative of clinical RBD.
Motor symptom severity in PD was quantified using the
Unified Parkinson’s Disease Rating Scale (UPDRS) and Hoehn
and Yahr staging (Hoehn & Yahr, 1967). Nineteen patients had
right side of symptom onset and 15 had left side of symptom
onset. The onset subgroups were too small to permit us to ana-
lyze data with respect to this variable. Levodopa equivalent
dosages (LED) were calculated based on previous reports with
LED: (regular levodopa dose3 1)1 (levodopa controlled-
release dose3 0.75)1 (pramipexole dose3 67.0)1 (ropinirole
dose316.67)1 (rotigotine316.67)1 (pergolide dose and
cabergoline dose367.0)1 (bromocriptine dose310)1 (regular
levodopa dose1 levodopa controlled-release dose3 0.75)
(3 0.25 if taking tolcapone or entacapone) (Gjerstad, Boeve,
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Wentzel-Larsen, Aarsland, & Larsen, 2008). None of the PD
participants were taking anticholinergic medications. Five were
taking sleep medications (clonazapam, seroquel, trazodone).
All patients received the Beck Depression Inventory-II (BDI)
and the Beck Anxiety Inventory (BAI) (Beck & Steer, 1993;
Beck, Steer, & Brown, 1996). Table 1 describes all PD-group
medications and other participant characteristics.
Sleep Measures
To measure activity during the sleep/wake cycle, the parti-
cipants wore wrist actigraphs (Actiwatch AW-64; Mini Mit-
ter, Sunriver, OR) continuously over a 1-week period on both
wrists. Data from the non-dominant wrist alone were used for
the current study, as per convention. The standard methods
for measuring sleep and wake cycles using actigraphy are that
each movement that is registered above the set sensitivity
level is considered an activity count (Sadeh & Acebo, 2002).
For the current study, the actigraphs were set to a medium
sensitivity with 40 counts assessed as ‘‘wake’’ and an epoch
length of 30 s. The Actiwatch data were downloaded to the
Actiware sleep software (Mini Mitter). Actigraphic measures
were averaged across the 7 days of monitoring. The measures
were sleep latency (first 10-min period with fewer than two
epochs of activity), sleep time (sum of time [in min] of epochs
not exceeding the sensitivity threshold), sleep efficiency (sleep
time divided by the time in bed multiplied by 100), wake after
sleep onset (total time awake after the first sleep onset period),
and movement and fragmentation index (number of 1-min
periods of immobility relative to the total number of immobility
phases). Reliability and validity studies in healthy adults have
demonstrated that actigraphy is highly correlated with poly-
somnography for differentiating sleep from wake states (Blood,
Sack, Percy, & Pen, 1997; Jean-Louis et al., 1996). The validity
of actigraphy in PD has been reported by showing correlations
of actigraphy measures to those of patient self-report (Stavitsky,
Saurman, McNamara, & Cronin-Golomb, 2010).
In addition to the actigraphs, each participant completed
a sleep diary over the 7 days of monitoring. The sleep
diary was adapted from a previously published diary from
the National Sleep Foundation to which were added ques-
tions pertinent to sleep/wake behaviors in PD. The sleep
diary included sections outlining daytime activity, ‘‘on/off’’
periods, daytime sleepiness, bed/rise times, time to sleep
onset, number of awakenings, morning motor symptom
ratings, morning refreshment, dreams, nocturnal hallucina-
tions and other night time symptoms. Daytime sleepiness
was also measured using the Epworth Sleepiness Scale
(Johns, 1991).
Cognitive Measures
The neuropsychological assessment was selected to be brief
enough to ensure adherence and comprehensive enough to
sample those cognitive domains known to be impaired in PD
and in individuals with sleep disorders. The cognitive tests
were administered when PD patients were in the ‘‘on’’ state
of effectiveness of their dopaminergic medication.
All participants received standardized neuropsychological
tests traditionally used to assess memory, attention/executive
function, and psychomotor domains. Each measure was
assigned to one dominant cognitive domain.
Memory
Measures of memory included the California Verbal Learn-
ing Test-II (CVLT-II) (Delis, Kramer, Kaplan, & Ober,
2000), a test of list-learning verbal memory, and the Brief
Visual Memory Test (BVMT) (Benedict, 2005), a test of
visual memory for figures on a page. For the CVLT, the
measures of interest were List A Trial 1-5 Total (total learn-
ing), Short Delay Free Recall, Long Delay Free Recall and
Yes/No Recognition. For the BVMT, the measures of interest
were Learning (best of trials 2 and 3), Delayed Recall, and
Yes/No Recognition.
Attention & executive function
In the present study, we used standardized neuropsycholo-
gical tests that are common and validated in clinical practice
and research to assess executive function. Tests of executive
function and attention included Verbal Fluency (FAS and
Category-Animals) (Benton & Hamsher, 1989), Ruff Figural
Fluency (Ruff, Light, & Evans, 1987) (total unique designs
and perseveration errors), Digit Span Backward (Wechsler,
1997), Spatial Span Backward (Wechsler, 1997b), the Trail-
Making Test B (Tombaugh, 2004), and the Stroop Color-
Word Test (Stroop, 1935).
Psychomotor function
To assess psychomotor functioning, we administered the
Trail Making Test A (Tombaugh, 2004) and the Purdue
Pegboard Test (Purdue, 1948), the latter of which correlates
with and is often used to predict motor severity in PD.
Table 1. Demographic and clinical variables in NC and PD
participants
NC (n5 18) PD (n5 35)
Age 64.4 (8.9) 66.2 (7.9)
Education 17.1 (2.6) 16.8 (2.4)
Men:women 8:10 22:13
BDI total 4.44 (2.9) 8.3 (4.7)*
BAI total 1.94 (2.8) 8.3 (4.9)*
UPDRS total n/a 25.1 (9.4)
Disease stagea n/a 2 (1-3)
Disease duration n/a 8.8 (5.1)
LED n/a 604.3 (283.5)
Dopamine agonist (%) n/a 77.1%
Note. Means (SD) are reported unless otherwise indicated. NC5 normal
control adults; PD5Parkinson’s disease; BDI5Beck Depression Inventory-
II; BAI5Beck Anxiety Inventory; UPDRS5Unified Parkinson’s Disease
Rating Scale; LED5Levodopa equivalent dose; n/a5not applicable.
*Significant difference at p, .01
aMedian (range).
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Statistical Analyses
Independent samples t tests were used to analyze differences
between PD and NC participants. Summary scores were
calculated for each cognitive domain (attention & executive
function, memory, and psychomotor function). The score of
each neuropsychological test was converted to a z-score based
on the means of the NC and averaged for each cognitive
domain. Pearson correlations were used to examine associa-
tions between sleep measures and summary scores within the
PD and NC groups separately. All analyses used a conservative
alpha of .01 to account for multiple comparisons. Multiple
regression analyses were performed to examine the relative
contribution of sleep quality and disease-related variables to
cognitive functioning in PD using sleep efficiency and UPDRS
total (motor symptom severity) as predictors, and summary
scores for each cognitive domain as criterion variables.
RESULTS
Although the patients were not demented, they performed
significantly more poorly than NC on multiple measures of cog-
nitive functioning (Table 2). In regard to attention and executive
functioning, the overall summary score was significantly different
between PD and NC participants. On the individual measures, PD
patients generated significantly fewer words on the FAS letter
test, drew fewer unique designs on the Ruff Figural Fluency test,
and had longer completion time on the Trail Making Test B. For
memory tests, the overall summary score was significantly lower
for PD than NC participants. Examining individual tests, PD
patients had lower scores on all CVLT-II measures of verbal
recall except long-delay recognition, and recalled fewer figures
on all BVMT measures of non-verbal memory. For tests of
psychomotor function, PD and NC were significantly different
on the summary score; as expected, PD patients performed
significantly worse than NC on the Purdue Pegboard Test and
were significantly slower on Trails A. On the actigraphy sleep
measures, PD patients showed significantly poorer sleep efficie-
ncy and more sleep fragmentation than NC participants (Table 3).
Excluding nine individuals with possible REM sleep disorder,
these findings remained significant, with sleep efficiency and
sleep fragmentation still different between PD and NC.
Correlations Between Sleep and Cognition
In the PD group, the attention/executive function summary score
was significantly correlated with sleep onset latency and sleep
efficiency (Figure 1). In the NC group the attention/executive
function summary score was significantly associated with total
sleep time and sleep fragmentation. Neither the memory nor the
psychomotor summary score was significantly associated with
any sleep measures for either the PD or NC (Table 4). No sig-
nificant correlations were found between Epworth Sleepiness
Scale total and performance in any of the cognitive domains.
As neither the BDI nor the BAI scores were significantly
related to sleep measures or cognitive summary scores for
Table 2. Comparison of cognitive performance in NC and PD participants
NC (n5 18) PD (n5 35) Significance
Attention & Executive Function (summary score) .005 (.52) 2.98 (1.1) .001
Verbal
Letter Fluency 57.0 (13.0) 39.9 (10.4) .0001
Category Fluency 53.3 (11.6) 45.3 (10.7) ns
WAIS-III Digit Span Backward 8.89 (2.7) 7.77 (2.4) ns
Visual
TMT B (seconds) 66.6 (15.2) 117.8 (63.2) .0001
Ruff Figural Fluency 90.7 (19.6) 75.1 (16.3) .004
WAIS-III Spatial Span Backward 7.39 (1.3) 6.29 (2.4) ns
Stroop Interference (index score) 22.37 (7.2) 24.18 (5.9) ns
Memory (summary score) .004 (.65) 21.03 (.91) .0001
Verbal
CVLT-II total learning 56.0 (9.7) 42.3 (12.9) .0001
CVLT-II short delay 11.8 (3.2) 8.06 (3.2) .0001
CVLT-II long delay 12.0 (3.7) 9.0 (3.8) .008
CVLT-II recognition 14.1 (2.4) 14.1 (1.7) ns
Visual
BVMT total learning 23.5 (6.9) 16.1 (6.7) .001
BVMT long delay 9.61 (2.7) 7.15 (3.2) .007
BVMT recognition 5.83 (.38) 5.14 (.89) .0001
Psychomotor (summary score) .04 (.93) 22.97 (2.9) .0001
TMT A (seconds) 25.0 (3.0) 37.8 (12.0) .0001
Purdue Pegboard (# pegs) 13.8 (1.8) 10.4 (2.2) .0001
Note. Means (SD) are reported. Units are number correct unless otherwise indicated. NC5 normal control adults; PD5 Parkinson’s
disease; WAIS5Wechsler Adult Intelligence Scale; CVLT-II5California Verbal Learning Test-II; BVMT5Brief Visual Memory
Test; TMT5Trail Making Test; ns5 not significant.
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either the PD or NC group, these were not used as covariates
for any analyses. Because PD patients with RBD have been
reported to demonstrate cognitive problems earlier in the
disease course than those without RBD (Sinforiani et al.,
2006; Vendette et al., 2007), the analyses were repeated
excluding the nine patients presenting with RBD symptoms.
Table 3. Actigraphy sleep results in NC and PD participants
NC (n5 18) PD (n5 35) Significance
Sleep onset latency (minutes) 18.8 (17.5) 29.6 (40.8) ns
Sleep efficiency (%) 80.6 (6.3) 68.7 (20.0) p, .002
WASO (minutes) 55.8 (14.0) 66.8 (34.6) ns
Total sleep time (minutes) 368.1 (42.3) 317.4 (120.8) ns
Sleep fragmentation index 16.2 (5.9) 29.0 (12.8) p, .0001
Means (SD) are reported. NC5 normal control adults; PD5Parkinson’s disease; WASO5wake after sleep onset; ns5 not significant.
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Fig. 1. Correlation plots of executive function/attention, memory, and psychomotor function summary scores as
dependent variables with actigraphy-derived sleep efficiency and with Unified Parkinson’s Disease Rating Scale (UPDRS)
total. PD group only. (a) Executive function/attention and sleep efficiency (r52.43; p, .01). (b) Executive function/
attention and UPDRS total (r52.32; p. .05). (c) Memory and sleep efficiency (r5 .26; p. .05). (d) Memory and
UPDRS total (r5 .41; p, .01). (e) Psychomotor function and sleep efficiency (r52.32; p. .05). (f) Psychomotor
function and UPDRS total (r5 .50; p, .01). Note: a higher sleep efficiency indicates better sleep whereas a higher
UPDRS score indicates worse symptoms, which is the reason for different direction of slopes in the figures.
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With these follow-up analyses, sleep efficiency was still
significantly related to attention and executive functioning.
Predictors of Cognitive Impairment
To answer the question of whether it was simply more severe
disease that caused both impaired sleep and cognition in patients
with PD, we conducted multiple regression analyses using
sleep efficiency and UPDRS total (motor symptom severity) as
predictors of cognitive impairment. When the attention and
executive function summary score was the dependent variable,
the overall model was significant, accounting for 21% of the
variance in performance. When the independent variables were
examined separately, sleep efficiency was a significant predictor
of performance (b5 .36; p, .05), but the UPDRS total was not
(b52.19; p. .05). When the memory summary score was the
dependent variable, the overall model was significant, account-
ing for 18% of the variance in performance. Unlike for attention
and executive function, sleep efficiency was not a significant
factor contributing to performance in the memory functioning
domain. Instead, in contrast to attention and executive function,
memory was significantly predicted by UPDRS total score
(b52.37; p, .05) but not by the sleep efficiency score
(b5 .12; p. .05). For the psychomotor summary score, the
overall model was significant, accounting for 27% of the var-
iance with only UPDRS total (b52.43; p, .05) and not sleep
efficiency (b5 .17; p. .05) being a significant predictor of
performance.
Removing the nine individuals with possible RBD
revealed the same results for the executive function and
attention analyses and psychomotor function analyses. For
the memory subscore, however, after those with RBD were
removed, neither sleep efficiency nor UPDRS total were
significant predictors of performance.
DISCUSSION
This study examined how aspects of sleep quality as mea-
sured by actigraphy were related to cognitive functioning in
patients with PD. In NC and PD participants, performance on
actigraphic measures of sleep was significantly related to
attention/executive function, demonstrating that the previously
reported association in healthy individuals and in those with
insomnia extends to patients with PD. There were no significant
associations between sleep quality and the aspects of memory
and psychomotor function assessed here; PD patients with
poorer sleep efficiency as measured by actigraphy exhibited
more attention/executive cognitive impairments but did not
display more memory or psychomotor impairments.
Patients with PD have been repeatedly shown to have poor
sleep, in particular problems with sleep efficiency and sleep
fragmentation, often resulting in severe sleep deprivation
(Comella, 2003; Stavitsky et al., 2010). There is some evi-
dence that disturbances of sleep and cognition in PD share at
least some neuropathological substrates, possibly including
the disruption of mesolimbic dopamine circuitry (Gagnon,
Petit, Latreille, & Montplaisir, 2008; Gunn, Naismith, &
Lewis, 2010). Here we have shown that sleep and cognitive
functioning are correlated, with worse sleep associated with
worse cognitive performance. The association we found
between sleep and cognitive functioning was not accounted
for by daytime sleepiness.
A question addressed in this study was whether the asso-
ciation between sleep efficiency and cognition could mainly
be accounted for by motor symptom severity. As PD is a
progressive neurodegenerative disorder, the number and
severity of symptoms increases with disease progression.
With longer disease duration and worsening of motor
symptoms, patients begin to exhibit worse sleep symptoms
(Maetzler, Liepelt, & Berg, 2009) and their cognitive func-
tioning also declines (Muslimovic, Post, Speelman, De Haan,
& Schmand, 2009; Verbaan et al., 2007). We examined the
contribution of disease severity and sleep efficiency to cognitive
performance and found that for attention/executive function,
which is most often associated with sleep disturbance, sleep
efficiency was a significant predictor of performance, whereas
motor symptom severity was not. For the psychomotor and
memory summary scores, by contrast, our analyses indicated
that it was motor symptom severity and not sleep quality that
Table 4. Correlations between actigraphy and cognitive performance in the PD and NC groups
ACT
SOL
ACT Sleep
Efficiency
ACT
WASO
ACT
TST
ACT Sleep
Fragmentation
UPDRS
Total
PD (n5 35)
Attention & Executive Summary Score 2.44*/.19 .43*/.18 2.11 .27 2.33 2.32
Memory Summary Score 2.24 .26 2.23 .11 2.30 2.41*/.17
Psychomotor Summary Score 2.32 .30 2.21 .18 2.22 2.50*/.25
NC (n5 18)
Attention & Executive Summary Score 2.16 .34 2.10 .64*/.41 2.57*/.32 n/a
Memory Summary Score 2.31 .09 .09 .23 2.41 n/a
Psychomotor Summary Score 2.23 .01 .28 .42 2.10 n/a
Note. Correlation coefficients (r values)/effect sizes for significant results are reported. Values reported are for summary scores for each cognitive domain.
*p, .01
NC5 normal control adults; PD5 Parkinson’s disease; ACT5 actigraphy; SOL5Sleep onset latency; WASO5wake after sleep onset; TST5 total sleep
time; UPDRS5Unified Parkinson’s Disease Rating Scale; n/a5 not applicable.
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predicted memory performance. These findings point to the
possible independence of individual cognitive impairments in
PD, with correspondingly distinct underlying pathophysiology.
Of note, when we removed individuals with possible REM
behavior disorder, we found that neither sleep nor UPDRS total
were significant predictors of memory performance. This may
in part be due to a decrease in power with fewer patients in
the sample size, or may support previous studies that have
shown that patients with RBD tend to decline faster in cognitive
functioning and are likely to be at the beginning stages of a more
rapid dementing process (e.g., Vendette et al., 2007).
The pathology of PD affects brain areas responsible for
cognitive functioning as well as for sleep/wake regulation
(Gagnon et al., 2008; Gunn et al., 2010). Hence, it is not
possible to determine from this study whether the relation of
sleep to cognition in PD reflects the underlying pathology
of the disease impacting both networks, the direct effect of
decreased sleep on attention/executive functioning, or a
combination of the two possibilities. The literature on sleep
and its effect on cognition has mostly centered on the clinical
presentation or waking performance of individuals after
sleep loss. Studies have begun to elucidate the effect of sleep
problems on daytime function by demonstrating their effect
on specific brain regions. For example, a study in older adults
(mean age, 67 years) found that electroencephalographic
(EEG) activity during sleep may be a marker of daytime
frontal function, specifically indicating the association between
frontal EEG activity during sleep and consequent daytime
performance on waking executive function (Anderson & Horne,
2003). This study as well as others have pointed out that sleep is
particularly important for the waking function of frontal regions
and in particular the prefrontal cortex in both younger adults
(Clark et al., 1998) and older adults (Anderson & Horne, 2003).
The association of sleep and executive function and attention is
particularly important in patients with PD, because the disorder
is characterized by frontal compromise (Zgaljardic et al., 2006).
The additional impact of sleep loss may be particularly detri-
mental, as shown by our results with the attention/executive
function measures.
Although psychomotor vigilance tasks are considered the
preferred assay for sensitivity to sleep loss in otherwise healthy
individuals (e.g., Rupp, Arnedt, Acebo, & Carskadon, 2004),
we saw no relation between sleep variables and psychomotor
test performance in this sample of PD patients. Performance
decrements most strongly related to sleep variables in this
sample were tasks of executive function and attention.
In healthy individuals, sleep loss is not unequivocally
related to executive function deficits. Indeed, previous
reports of the relation between sleep and executive function
may have been due to the failure to isolate specific compo-
nents of executive functions tests; when this is done, effects
of sleep loss on executive functions are less clear (Tucker,
Whitney, Belenky, Hinson, & Van Dongen, 2010). More
precision is required in analyzing components of putative
executive function tasks that are affected by sleep restriction.
Nevertheless, it appears that some higher-level cognitive
control process best described as an ‘‘executive control’’
process is affected by sleep changes in PD (see also Groeger,
Lo, Burns, & Dijk, 2011, for a similar perspective).
Subgroups of PD have received much attention in the
recent PD literature, as they may be important to under-
standing disease and treatment variability as well as to general
understanding of neural networks related to the specificity of
various functions, including cognition and mood. Studies often
examine disease-related variables in individuals with PD
through consideration of subgroups by age of onset, type of
initial motor symptom, side of initial motor symptom, and
gender. These meaningful subgroups can give insight into har-
bingers of the disease as well as treatment implications and can
help with understanding the physiologic substrates of disease
symptoms. Research into complex disease states such as PD
often yields conflicting results, and much debate has ensued
over the years especially about the essence of cognitive pro-
blems in this disorder. Some investigators have approached PD
heterogeneity by focusing on neuropsychiatric features of the
disease including presence or absence of depression, hallucina-
tions and sleep disturbances (Bronnick, Aarsland, & Larsen,
2005). A recent review of the heterogeneity of PD suggested
that sleep disturbances may be an important factor impacting the
variability of the disease (Gunn et al., 2010). The present study
is the first to our knowledge to demonstrate that disturbed sleep
is related to the cognitive problems in PD and that sleep
impairment contributes to the heterogeneity of the disease.
Given the potential contribution of sleep disturbance to the
heterogeneity of the clinical presentation of PD, it is impor-
tant in future studies to explore whether there are differences
by subgroup (i.e., gender, side, and type of predominant
motor symptom) in the association of sleep and cognition in
this disorder. Previous studies have reported gender differ-
ences in sleep (Bordelon & Fahn, 2006; Miller & Cronin-
Golomb, 2010) as well as differences by side and motor
symptom at onset (Alves, Larsen, Emre, Wentzel-Larsen, &
Aarsland, 2006; Cronin-Golomb, 2010; Stavitsky et al.,
2008) with regard to sleep and cognitive functioning in PD.
In the present study, subgroup analyses were not performed
due to power limitations associated with sample sizes. Future
studies should explore whether sleep disruption has a differ-
entially greater impact on cognitive performance in men and
women and by motor subgroups in PD.
A potential limitation of this study was that we used acti-
graphy rather than polysomnography (PSG), which is the
gold standard for studying sleep. Although actigraphy is a
useful and in some respects a preferred method of assessing
many aspects of sleep in PD, as compared to self-report
(Stavitsky et al., 2010; Stavitsky & Cronin-Golomb, 2011),
actigraphy cannot differentiate between nocturnal activity
due to wakefulness and nocturnal activity due to other common
sleep disturbances of PD such as REM behavior disorder, per-
iodic limb movements, or sleep apnea. All of these nocturnal
sleep problems disrupt sleep and, therefore, decrease sleep
quality. Sleep-disordered breathing in particular has been asso-
ciated with cognitive deficits, such as those related to problems
with executive function, vigilance, psychomotor function, and
memory (see Decary, Rouleau, & Montplaisir, 2000 for review).
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To evaluate the presence of the common sleep disturbances in
PD, we used a self-report measure in addition to actigraphy and
determined that nine of the PD patients had been diagnosed with
sleep-disordered breathing. Removing the data from these indi-
viduals did not change the main finding of the study, however,
which was that attention and executive function were associated
with sleep quality in patients with PD. It should be noted that
undiagnosed sleep disorders are common in PD. As PSG was
not used to ensure the absence of sleep disorders, there may have
been individuals in our study who had sleep-disordered breath-
ing, REM sleep behavior disorder or restless legs syndrome,
which may have contributed to the results.
In summary, the current study is the first to demonstrate that
sleep quality in PD is significantly correlated with cognitive
functioning. Hence, the association between poor sleep and
impaired cognition previously reported in other populations
(Bastien et al., 2003; Blackwell et al., 2006) can be extended to
those with PD. Among the most important findings was that
the best predictor of the performance of PD patients on mea-
sures of attention and executive functioning was sleep effi-
ciency, accounting for more variance than disease severity. By
contrast, we found in the same patients that psychomotor
function was more likely to be associated with disease severity
than with sleep. Memory appeared to be associated with
disease severity rather than with sleep, but the relation did not
hold when we eliminated data from patients with symptoms of
REM behavior disorder. In PD as with other studied popula-
tions, the integrity of sleep appears to be a significant factor
in waking cognitive performance particularly in regard to
attention and executive function. Further research is needed to
investigate the neuroanatomical substrates underlying sleep
and cognitive functioning in this disorder. In those with
insomnia, it has been reported that improving sleep through
behavioral therapy has a positive impact on waking cognitive
function (Altena, Van Der Werf, Strijers, & Van Someren,
2008) and increases waking frontal activation (Altena, Van
Der Werf, Sanz-Arigita et al., 2008). Understanding the rela-
tion of sleep efficiency and cognition in PD is particularly
important because sleep problems are amenable to treatment,
and both sleep and cognitive problems impact the quality of life
of those with PD.
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